OBIO — Orchestra Biomed Holdings Share News
0.000.00%
Last trade - 00:00- $366.04m
- $290.92m
- $33.48m
U.S. STOCKS ON THE MOVE-Kimberly-Clark, Hims & Hers Health, CNH Industrial
Orchestra BioMed drops after $40 mln equity raise
Brief: Orchestra Biomed Receives FDA Approval Of Ide To Initiate U.S. Coronary Pivotal Trial Randomizing First-In-Class Sirolimus-Angioinfusion Balloon, Virtue Sab, Head-To-Head With Paclitaxel-Coated Balloon
Brief: Orchestra Biomed Receives FDA Breakthrough Device Designation For Avim Therapy
Brief: Orchestra Biomed May Offer And Sell Shares Of Up To $100 Mln
Brief: Orchestra BioMed Board Size Increased To Eight Directors
Brief: Orchestra BioMed Holdings Files For Mixed Shelf Of Upto $300 Mln
U.S. RESEARCH ROUNDUP-Aclaris Therapeutics, Beauty Health Co, Vicarious Surgical
Brief: Orchestra BiomMed Says Expected Operating Cash Runway Sufficient Into 2H 2026, Beyond Anticipated Backbeat Top-Line Results Readout, Based On Internal Forecast
Brief: Orchestra BioMed Q3 EPS USD -0.37
Brief: Orchestra Biomed Holdings Says Expectation Is Initiation Of Virtue Isr-Us Pivotal Study Evaluating Efficacy Of Virtue Sab To Be Postponed Till 2024
Brief: Orchestra Biomed Set To Join Russell 3000® And Other Ftse Russell Indexes
Brief: Orchestra Biomed Appoints Andrew Taylor As Chief Financial Officer
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
Brief: Orchestra Biomed Reports First Quarter 2023 Financial Results And Provides Business Update
Brief: Health Sciences Acquisitions Corp 2 - On Jan 19, Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Orchestra Biomed™ Announces Strategic Collaboration, Closing Of $110 Million Private Equity Financing And Plans To List On Nasdaq
Brief: Health Sciences Acquisitions Corporation 2 Announces Pricing Of Upsized $139.1 Million IPO